Methyl 5-[N-(2-methoxycarbonyl-1-methylvinyl)carbamoyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate monohydrate

被引：0

作者：

Sun, Feng-Xia ^{[1
]}

Yu, Yi-Feng ^{[1
]}

Wang, Shuai ^{[1
]}

Xing, Cui-Juan ^{[1
]}

机构：

[1] Hebei Univ Sci & Technol, Coll Chem & Pharmaceut Engn, Shijiazhuang 050018, Peoples R China

来源：

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2006年 / 62卷

关键词：

D O I：

10.1107/S1600536806045284

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

The title compound, C21H25N3O7, is a nefidipine analog. The crystal packing is stabilized by intermolecular O-H center dot center dot center dot O hydrogen bonds, which link the molecules into chains running parallel to the c axis.

引用

页码：O5379 / O5380

页数：2

共 8 条

[1] *BRUK AXS INC, 1997, SMART SAINT SHELXTL
[2] 1,4-DIHYDROPYRIDINES - EFFECTS OF CHIRALITY AND CONFORMATION ON THE CALCIUM-ANTAGONIST AND CALCIUM AGONIST ACTIVITIES
GOLDMANN, S
STOLTEFUSS, J
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1991, 30 (12): : 1559 - 1578
[3] HOFMANN HJ, 1990, J MOL STRUC-THEOCHEM, V205, P1
[4] Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR
[5] Sheldrick G.M., 1996, SADABS VERSION 2008
[6] 3-(benzotriazol-1-yl) 5-ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate ethyl acetate hemisolvate
Sun, Feng-Xia
Fu, De-Cai
Yu, Yi-Feng
[J]. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O4207 - O4208
[7] Yiu SH, 1999, DRUG DEVELOP RES, V48, P26, DOI 10.1002/(SICI)1098-2299(199909)48:1<26::AID-DDR4>3.0.CO
[8] 2-M

← 1 →